Your search for comorbidities returned 146 results

For patients with obstructive sleep apnea, use of continuous positive airway pressure offers cardiovascular benefits.

A discussion of the updated AHA/ACC guidelines for treating chronic heart disease with Dr Dave L Dixon, PharmD, and Dr Salim S Virani, MD, PhD.

Researchers assessed patients with Omicron-associated COVID-19 to identify factors related to the highest proportion of cases and to assess these factors’ prognostic value.

COVID-19 induces a range of negative cardiac effects, such as hypoxic respiratory failure and hypoxemia, microvascular injury, venous thromboembolism, and pulmonary embolism.

Researchers investigated the risk for diabetes among patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs.

Investigators assessed the impact of a recent 2019 label change on the use of febuxostat among patients with gout.

Several associations, including the AHA, ACC, and NLA, have issued new guidelines for management of patients with chronic coronary disease.

A meta-analysis explored associations between population-level tobacco control laws and respiratory and other health-related outcomes.

Semaglutide is a GLP-1 receptor agonist.

Hypoxic and ventilatory burden in obstructive sleep apnea predict cardiovascular disease morbidity and mortality.